-The Times of India NEW DELHI: Faced with the scary prospect of losing lives to simple infections in the future, India is finally waking up to the dangers of reckless antibiotic use. The Indian Medical Association, a pan-India voluntary organization of doctors, will on Sunday launch a nationwide awareness programme on overuse of these live-savers, a practice that has led to emergence of drug-resistant organisms. IMA will also ask fellow practitioners to...

-PTI Srinagar: When the floods wreaked havoc in Kashmir and plunged most parts of the Valley into darkness, few doctors at a lone maternity care hospital in Srinagar, lent a ray of light to people's lives by performing birth surgeries under candlelight. Doctors at the Lal Ded Hospital, whose ground floor was submerged by flood waters from Jhelum, performed six deliveries under the candlelight as the electricity supply to the hospital was...

-The Times of India MUMBAI: In a move that will disappoint many Patients, the government has withdrawn certain powers of the drug pricing regulator that allowed it to cap prices of widely prescribed anti-diabetes, cancer, HIV, tuberculosis and cardiac medicines. The National Pharmaceutical Pricing Authority (NPPA) said it is withdrawing "with immediate effect" - a guideline that had allowed it to put price caps on crucial medicines - to comply with a...

-The Telegraph Kolkata: The Bengal government's decision to select insurance companies quoting the lowest premiums for a centrally funded health care scheme has hit private hospitals that are refusing Patients citing non-payment of claims by the firms. Senior officials of the health department said thousands of poor Patients registered under the Rashtriya Swasthya Bima Yojana were being refused admission by hospitals and nursing homes across the state every month. The registered families...

-The Business Standard A ray of hope for Indian generic drug makers Gilead Sciences, the California-headquartered biotechnology company, has authorised seven India-based drug makers - Cipla, Ranbaxy, Mylan, Strides Arcolab, Hetero, Cadila Healthcare and Sequent Scientific - to manufacture and sell the generic versions of its hepatitis C medicine, Sovaldi, in 91 developing countries. Earlier in the week, Lupin, the fourth largest Indian drug maker, announced that it will develop and supply...